Loading...
Loading...
All product recalls associated with STAQ Pharma, Inc..
Total Recalls
1000
Past Year
1000
Class I (Serious)
127
Most Recent
Jan 2026
Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.
Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A
Due to a software defect, the Philips StentBoost Live R2.0 might not process X-ray images of the current run and instead show an image processed in a previous run. The image shown could be from the same patient or from a different patient.
Malfunction of the hand pendant controlling movement of the therapy couch and nozzle may result in unintentional motion. Patient injury is possible if they come in contact with the nozzle or other objects in the treatment room.
Product may be contaminated with Listeria monocytogenes.
Incorrect Labeling: No Allergen Statement and No Ingredient Statement
The fluoroscopic dose rate might exceed the conforming value during biplane fluoroscopy.
Illegal importation of COVID-19 AG Test kits into the U.S. The COVID-19 Ag Test are not approved, cleared or authorized for distribution within the U.S.
This lot may have an elevated risk of leakage from the Air-Inlet Filter of the device. Leakage of the Air-Inlet Filter may increase the risk of decreasing the dose of medication delivered to the patient, cause delays in treatment due to the need to replace the device or may cause contamination of the fluid path that can lead to bloodstream infection.
One lot of product was distributed in unsealed packaging
Due to partially assembled valved dressing that has a hole within it instead of the intended non-valved dressing in the package resulting in that the dressing cannot be centered over the open chest wound and create an occlusive seal due to the hole being present.
Firm learned of the potential for cracks to form in the conductivity sensors during use, which may lead to a leak in the dialysate circuit. This could result in excessive ultrafiltration or insufficient ultrafiltration depending on whether the dialysis machine is equipped with a Dialysis Fluid filter.
Samsung SDI Co., Ltd. (Samsung SDI) is recalling certain High Voltage Battery Packs, part numbers LX68-10C790-G-PIA3AB, LX68-10C790-G-PIA3AD, 05193168AG, 05193168AH, LX68-10C790-G-PIA3AC, 05193168AE, and 05193168AF. The high voltage battery may fail, resulting in a sudden loss of drive power.
Subpotent Drug: FDA analysis has revealed some bottles of these products were sub potent for ethanol.
Subpotent Drug: FDA analysis has revealed some bottles of these products were sub potent for ethanol.
Distribution of Defibrillators that are not approved or cleared for distribution US Market.
Excessive ultraviolet-C radiation
Chrysler (FCA US, LLC) is recalling certain 2019-2020 Ram 2500 and Ram 3500 vehicles, Ram 3500 Cab Chassis, 4500 Cab Chassis, 5500 Cab Chassis and 3500 Cab Chassis with a gross vehicle weight rating (GVWR) of less than 10,000 lbs. The windshield wiper arms may loosen, possibly causing the wipers to function improperly and reduce the driver's visibility in certain weather conditions.
This recall involves bottles of Geri-Care Brand over-the-counter acetaminophen and aspirin. The acetaminophen is 500mg with 1,000 tablets in the bottle. The aspirin was sold in 81mg with 300 and 1,000 tablets in the bottle and 325mg with 250 and 1,000 tablets in the bottle. Product Count Extra Strength Acetaminophen 500mg Tablets 1,000 Regular Strength Enteric Coated Aspirin 325mg Tablets 250 Regular Strength Enteric Coated Aspirin 325mg Tablets 1,000 Adult Low Dose Enteric Coated Aspirin 81mg Tablets 300 Adult Low Dose Enteric Coated Aspirin 81mg Tablets 1,000
Presence of Particulate Matter; product complaint of hair discovered in a vial within the lot
Undeclared milk allergen